According to the terms of the transaction, WBA shareholders will receive $11.45 per share in cash at the closing.

ST. LOUIS, March 12, 2025 /PRNewswire/ -- Emerson (NYSE: EMR) today announced that it has completed its acquisition of all ...

Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million in cash to gain access to its lead drug ...

AspenTech's shares of common stock have ceased trading on the NASDAQ. Goldman Sachs & Co. LLC and Centerview Partners LLC served as financial advisors to Emerson, and Davis Polk & Wardwell LLP ...

Goldman Sachs & Co. LLC, Centerview Partners LLC, and Davis Polk & Wardwell LLP served as financial advisors and legal advisor, respectively, to Emerson during the acquisition process. Emerson ...

The acquisition has led to the cessation of trading of AspenTech’s common stock on the NASDAQ. Goldman Sachs & Co. LLC, Centerview Partners LLC, and Davis Polk & Wardwell LLP served as financial ...

Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop ...

Centerview Partners LLC is acting as financial advisor and Goodwin Procter is serving as legal counsel to Repligen Corporation.